MedCity

UCLPartners is a founding partner of MedCity, a collaboration between academic, NHS and government organisations which aims to make London and the greater south east of England a world-leading life sciences cluster.

Launched in April 2014 to promote and grow the world-leading life sciences cluster of England’s greater south east, MedCity promote life sciences investment, entrepreneurship and industry in the region by:

  • Providing a single front door and concierge service for industry and investors looking for partners, infrastructure and expertise
  • Facilitating and supporting collaboration across all parts of the sector to turn innovations into commercial products and services
  • Fostering an environment that supports and encourages entrepreneurialism
  • Raising awareness globally of the region’s rich life sciences ecosystem

MedCity aims to position the greater south east of England as a world-leading, interconnected region for life sciences research, development, manufacturing and commercialisation to stimulate greater economic growth.

MedCity is a collaboration between the Mayor of London, UCLPartners, Imperial College Academic Health Science Centre, King’s Health Partners, Cambridge Health Partners and Oxford Academic Health Science Centre.

The UCLPartners AHSC is renowned for collaborative working, bringing together academics, clinicians and patients through its six Academic Medical Centres (AMCs). MedCity builds on this foundation by linking UCLPartners with the breadth and strength of life science expertise across London and the South East.

UCLPartners has made a major contribution to MedCity through our clinical trials expertise. By bringing together the AHSC, the NIHR Clinical Research Network (CRN) North Thames, the NIHR CLAHRC North Thames and UCLPartners’ status as a Quintiles Prime Site, UCLPartners is able to offer companies developing new medicines, devices and products, the opportunity to work with one of the most diverse populations in the country.

Since its launch in April 2014, MedCity’s work has focused on supporting both international companies and home-grown entrepreneurs to do business in the region.

Activities include promoting life sciences within the investment community by building a community of angel investors through its Angels in MedCity programme and partnering with the London Stock Exchange to engage generalist brokers and investors.

It leads work to position London as a leading centre for digital health research and entrepreneurship, and supports entrepreneurs and emerging companies to understand the route to market, for example by mapping innovation adoption paths in the NHS.

It also works with companies to help them find the right infrasrtucture, partners, and expertise in the region, as well as guide them through the regulatory frameworks.